Biomerica (BMRA) Shareholder's Equity Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -17.87% |
| Nov 30, 2025 | -15.09% |
| Aug 31, 2025 | -14.76% |
| May 31, 2025 | -21.00% |
| Feb 28, 2025 | -17.23% |
| Nov 30, 2024 | -16.87% |
| Aug 31, 2024 | -15.32% |
| May 31, 2024 | -10.61% |
| Feb 29, 2024 | -9.69% |
| Nov 30, 2023 | -5.59% |
| Aug 31, 2023 | -5.05% |
| May 31, 2023 | -6.22% |
| Feb 28, 2023 | 8.56% |
| Nov 30, 2022 | 28.98% |
| Aug 31, 2022 | 31.93% |
| May 31, 2022 | 27.88% |
| Feb 28, 2022 | 35.13% |
| Nov 30, 2021 | 26.36% |
| Aug 31, 2021 | 29.24% |
| May 31, 2021 | 28.73% |
| Aug 31, 2020 | 43.17% |
| May 31, 2020 | 46.84% |
| Feb 29, 2020 | -0.97% |
| Nov 30, 2019 | -12.38% |
| Aug 31, 2019 | -11.14% |
| May 31, 2019 | -8.64% |
| Feb 28, 2019 | -9.80% |
| Nov 30, 2018 | -6.93% |
| Aug 31, 2018 | -9.68% |
| May 31, 2018 | -8.25% |
| Aug 31, 2017 | -9.05% |
| May 31, 2017 | -8.78% |
| Feb 28, 2017 | -5.59% |
| Nov 30, 2016 | -2.57% |
| Aug 31, 2016 | -3.05% |
| May 31, 2016 | -3.64% |
| Feb 29, 2016 | -0.84% |
| Nov 30, 2015 | -0.24% |
| Aug 31, 2015 | 1.65% |
| May 31, 2015 | 4.00% |
| Feb 28, 2015 | 3.09% |
| Nov 30, 2014 | 5.48% |
| Aug 31, 2014 | 8.61% |
| May 31, 2014 | 10.95% |